Drawing for MYELOMA SQUARE

USPTO serial 87697619

MYELOMA SQUARE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GALBO, AMANDA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MYELOMA SQUARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Camille M. Miller

Camille M. Miller COZEN O'CONNOR1650 Market Street, Suite 2800One Liberty PlacePHILADELPHIA, PA 19103

Goods and services

ClassDescriptionStatusFirst use
042Providing medical and scientific research information in the field of pharmaceuticals and certain diseasesACTIVE—
044Support services, namely, providing healthcare and wellness information to individuals with a life-changing or life-threatening disease to help these individuals take an active role in their healthcare and help others with their diseases; programs in the nature of providing medical counseling and medical information in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; providing a web site featuring medical information; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed in formation to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmaceutical advice; providing medical information, consultancy and advisory servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 14, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 14, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 15, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 13, 2020EX3GSOU EXTENSION 3 GRANTED—
Apr 13, 2020EXT3SOU EXTENSION 3 FILED—
Apr 13, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 18, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 16, 2019EX2GSOU EXTENSION 2 GRANTED—
Sep 16, 2019EXT2SOU EXTENSION 2 FILED—
Sep 16, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 16, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 12, 2019EX1GSOU EXTENSION 1 GRANTED—
Apr 12, 2019EXT1SOU EXTENSION 1 FILED—
Apr 12, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 13, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 18, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 18, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 29, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 10, 2018ALIEASSIGNED TO LIE—
Aug 1, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 3, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 3, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 3, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2018DOCKASSIGNED TO EXAMINER—
Dec 6, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 30, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance